|Articles|October 1, 2018
- Pharmaceutical Executive-10-01-2018
- Volume 38
- Issue 10
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's Emerging Pharma Leaders 2018about 7 years ago
Choosing the Right Track: Pharma & Healthcare MBAsabout 7 years ago
Getting Where You Need to Goabout 7 years ago
Vienna’s Vision on Health Regulation in Europeabout 7 years ago
FDA Launches Major Push for New Antimicrobialsabout 7 years ago
Medical Affairs’ Search for MeaningNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
